down arrow

AquaBounty Technologies, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US03842K3095
USD
1.02
0.06 (5.82%)

Dec 04

NAS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

0.951.05

52 Week

0.472.95
Valuation
Technical
Day's Volume

CASH

28.72 k

Shareholding (Mar 2025)

FII

0.04%

Held by 8 FIIs

DII

96.69%

Held by 3 DIIs

Promoter

0.00%

How big is AquaBounty Technologies, Inc.?

22-Jun-2025

As of Jun 18, AquaBounty Technologies, Inc. has a market capitalization of 2.92 million, with net sales of 0.71 million and a net profit of -64.46 million over the latest four quarters. The company reported shareholder's funds of 15.84 million and total assets of 34.06 million as of Dec 24.

Market Cap: As of Jun 18, AquaBounty Technologies, Inc. has a market capitalization of 2.92 million, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, AquaBounty Technologies, Inc. reported net sales of 0.71 million and a net profit of -64.46 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 15.84 million and total assets of 34.06 million.

Read More

What does AquaBounty Technologies, Inc. do?

22-Jun-2025

AquaBounty Technologies, Inc. focuses on the research and commercialization of antifreeze proteins to enhance aquaculture productivity. It is a micro-cap company with a market cap of $2.92 million and reported a net profit of $1 million in March 2025.

Overview: <BR>AquaBounty Technologies, Inc. is engaged in the research, development, and commercialization of antifreeze proteins and focuses on managing aquaculture productivity within the Pharmaceuticals & Biotechnology industry, categorized as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Net Profit: 1 Million (Quarterly Results - Mar 2025) <BR>Market Cap: USD 2.92 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.01 <BR>Return on Equity: -104.55% <BR>Price to Book: 0.17<BR><BR>Contact Details: <BR>Address: 2 Clock Tower Pl Ste 395, MAYNARD MA: 01754-2539 <BR>Tel: 1 978 6486000 <BR>Website: https://aquabounty.com/

Read More

Who are in the management team of AquaBounty Technologies, Inc.?

22-Jun-2025

As of March 2022, the management team of AquaBounty Technologies, Inc. includes Non-Executive Independent Chairman Richard Clothier, CEO Sylvia Wulf, and Non-Executive Directors Rick Sterling, Richard Huber, Christine St.Clare, and James Turk. They guide the company's strategic direction.

As of March 2022, the management team of AquaBounty Technologies, Inc. includes the following individuals:<BR><BR>- Mr. Richard Clothier, who serves as the Non-Executive Independent Chairman.<BR>- Ms. Sylvia Wulf, who is the President, Chief Executive Officer, and Executive Director.<BR>- Mr. Rick Sterling, who is a Non-Executive Director.<BR>- Mr. Richard Huber, who is a Non-Executive Independent Director.<BR>- Ms. Christine St.Clare, who is a Non-Executive Independent Director.<BR>- Mr. James Turk, who is also a Non-Executive Independent Director. <BR><BR>This team is responsible for guiding the strategic direction of the company.

Read More

Is AquaBounty Technologies, Inc. overvalued or undervalued?

25-Jun-2025

As of May 15, 2025, AquaBounty Technologies, Inc. is considered overvalued with troubling financial metrics, including a price to book value of 0.18 and a return on equity of -104.55%, and has significantly underperformed the S&P 500, declining by 54.53% over the past year.

As of 15 May 2025, AquaBounty Technologies, Inc. has moved from a grade of risky to does not qualify, indicating significant concerns regarding its financial health. The company is currently considered overvalued, particularly given its negative performance metrics. Key ratios include a price to book value of 0.18, an EV to EBIT of -0.18, and an EV to EBITDA of -0.19, all of which reflect a troubling financial situation.<BR><BR>In comparison to its peers, AquaBounty's financial ratios are significantly worse than those of Catalyst Biosciences, Inc., which has a P/E ratio of 90.02, and Elutia, Inc., which is rated risky with an EV to EBITDA of -4.64. Additionally, AquaBounty's return on capital employed (ROCE) stands at a staggering -93.65%, and its return on equity (ROE) is at -104.55%, further emphasizing its struggles. The company's stock has underperformed relative to the S&P 500, particularly over the past year, where it has declined by 54.53% compared to the index's increase of 10.26%.

Read More

Is AquaBounty Technologies, Inc. technically bullish or bearish?

20-Sep-2025

As of September 4, 2025, AquaBounty Technologies, Inc. has shifted to a bullish trend, supported by positive indicators like MACD and Bollinger Bands, despite a bearish weekly RSI, and has outperformed the S&P 500 with returns of 29.57% and 107.00% over the past week and month, respectively.

As of 4 September 2025, the technical trend for AquaBounty Technologies, Inc. has changed from mildly bullish to bullish. The current stance is bullish, driven by weekly MACD and KST indicators showing bullish signals, along with bullish readings from Bollinger Bands and On-Balance Volume. Daily moving averages also confirm a bullish trend. However, the weekly RSI is bearish, indicating some short-term weakness. <BR><BR>In terms of performance, AquaBounty has significantly outperformed the S&P 500 over the past week and month, with returns of 29.57% and 107.00% respectively, compared to the S&P 500's 1.05% and 2.33%.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 5 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.57

stock-summary
Return on Equity

-93.37%

stock-summary
Price to Book

0.36

Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-3 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-12.82%
0%
-12.82%
6 Months
24.39%
0%
24.39%
1 Year
9.68%
0%
9.68%
2 Years
-47.69%
0%
-47.69%
3 Years
-92.71%
0%
-92.71%
4 Years
-97.84%
0%
-97.84%
5 Years
-99.19%
0%
-99.19%

AquaBounty Technologies, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News

Is AquaBounty Technologies, Inc. technically bullish or bearish?

As of 4 September 2025, the technical trend for AquaBounty Technologies, Inc. has changed from mildly bullish to bullish. The current stance is bullish, driven by weekly MACD and KST indicators showing bullish signals, along with bullish readings from Bollinger Bands and On-Balance Volume. Daily moving averages also confirm a bullish trend. However, the weekly RSI is bearish, indicating some short-term weakness. In terms of performance, AquaBounty has significantly outperformed the S&P 500 over the past week and month, with returns of 29.57% and 107.00% respectively, compared to the S&P 500's 1.05% and 2.33%....

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
2.47%
EBIT Growth (5y)
4.52%
EBIT to Interest (avg)
-18.93
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.01
Sales to Capital Employed (avg)
0.02
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
12.42%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.18
EV to EBIT
-0.18
EV to EBITDA
-0.19
EV to Capital Employed
0.17
EV to Sales
2.83
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-93.65%
ROE (Latest)
-104.55%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
Bullish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 5 Schemes (3.28%)

Foreign Institutions

Held by 8 Foreign Institutions (0.04%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Mar 2025",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -666.67% vs 117.65% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.80",
          "val2": "-1.60",
          "chgp": "-12.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.10",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.50",
          "val2": "2.00",
          "chgp": "-175.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-3.40",
          "val2": "0.60",
          "chgp": "-666.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -100.00% vs -19.35% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -312.32% vs -24.32% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "2.50",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-8.60",
          "val2": "-25.20",
          "chgp": "65.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.30",
          "val2": "0.30",
          "chgp": "666.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-101.90",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-113.80",
          "val2": "-27.60",
          "chgp": "-312.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "-11,047.50%",
          "chgp": "1,104.75%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-1.80
-1.60
-12.50%
Interest
0.10
0.10
Exceptional Items
-1.50
2.00
-175.00%
Consolidate Net Profit
-3.40
0.60
-666.67%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
stock-summary Compare with Peers
Net Sales

QoQ Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -666.67% vs 117.65% in Mar 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
0.00
2.50
-100.00%
Operating Profit (PBDIT) excl Other Income
-8.60
-25.20
65.87%
Interest
2.30
0.30
666.67%
Exceptional Items
-101.90
0.00
Consolidate Net Profit
-113.80
-27.60
-312.32%
Operating Profit Margin (Excl OI)
0.00%
-11,047.50%
1,104.75%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -100.00% vs -19.35% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -312.32% vs -24.32% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About AquaBounty Technologies, Inc. stock-summary
stock-summary
AquaBounty Technologies, Inc.
Pharmaceuticals & Biotechnology
AquaBounty Technologies, Inc. is a engaged in research, development and commercialization of the commercial viability of a group of proteins, antifreeze proteins (AFPs). The Company focuses on the managing aquaculture productivity. It offers AquAdvantage Salmon (AAS), which can be grown in contained, land-based facilities. It offers AquAdvantage Salmon for land-based facilities that can be built closer to consumers to manage the need for air freight shipping and transportation. The Company's subsidiaries include AquaBounty Canada, Inc., which operates a commercial biotechnology laboratory that conducts research and development programs related to the Company's technologies; AquaBounty Panama, S. de R.L.; AquaBounty Farms, Inc.; AquaBounty Farms Indiana LLC, and AquaBounty Brasil Participacoes Ltda., which conducts commercial trials of the Company's AquAdvantage Salmon.
Company Coordinates stock-summary
Company Details
2 Clock Tower Pl Ste 395 , MAYNARD MA : 01754-2539
stock-summary
Tel: 1 978 6486000
stock-summary
https://aquabounty.com/
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."